| Old Articles: <Older 47291-47300 Newer> |
|---|
 |
The Motley Fool
February 22, 2011
Brian Orelli |
Biogen and Elan's Growing Problem More cases of potentially lethal PML.   |
The Motley Fool
February 22, 2011
Matt Koppenheffer |
George Washington Will Make You a Better Investor Can we adapt George Washington's Rules of Civility for investing in stocks? Sure, if we squint really hard. |
The Motley Fool
February 22, 2011
Dan Caplinger |
Higher Rates Will Hurt These Stocks Yields are headed up. Some stocks will suffer. |
The Motley Fool
February 22, 2011
Todd Wenning |
Dividend Report Card: Philip Morris International Does the tobacco giant's dividend pass the test? |
The Motley Fool
February 22, 2011
Sean Williams |
V.F. Corp. Wrangles in Profits, But Can It Continue? Is this retail company a one-hit wonder or can it continue to deliver for shareholders? |
The Motley Fool
February 22, 2011
Morgan Housel |
Staring Trouble in the Face The S&P 500 officially doubled from its March 2009 lows last week. This was the fastest the index has ever doubled since its debut in the 1950s. |
The Motley Fool
February 22, 2011
Eric Bleeker |
Can the Worst Internet Stocks of 2010 Rebound in 2011? 2011 has started out with a boom; can last year's underperformers in the Internet space capitalize? |
The Motley Fool
February 22, 2011
Travis Hoium |
Melco Crown Is Still Behind in Macau The gaming company is still lagging behind competitors despite improving results. |
The Motley Fool
February 22, 2011
Ryan McBride |
Forest Labs Snaps Up Clinical Data This deal is the latest proof that drug developers with FDA-approved treatments remain hot buyout targets in a pharma industry that is starved for new products to replace brand-name drugs. |
The Motley Fool
February 22, 2011
Rich Smith |
Rosetta Stone: "Muerto," "Tot," or Just Plain "Dead"?" An earnings warning hammers the multilingual stock. |
| <Older 47291-47300 Newer> Return to current articles. |
